187 related articles for article (PubMed ID: 3283777)
21. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
[TBL] [Abstract][Full Text] [Related]
22. [Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ; Rössner M
Vasa Suppl; 1987; 20():375-8. PubMed ID: 3321494
[No Abstract] [Full Text] [Related]
23. The treatment of chronic cerebrovascular insufficiency. A double-blind study with pentoxifylline ('Trental' 400).
Harwart D
Curr Med Res Opin; 1979; 6(2):73-84. PubMed ID: 380914
[No Abstract] [Full Text] [Related]
24. Effects of pentoxifylline on olfactory sensitivity: a postmarketing surveillance study.
Gudziol V; Hummel T
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):291-5. PubMed ID: 19289709
[TBL] [Abstract][Full Text] [Related]
25. Treatment of chronic cerebrovascular disease in elderly patients with pentoxifylline.
Blume J; Rùhlmann KU; de la Haye R; Rettig K
J Med; 1992; 23(6):417-32. PubMed ID: 1293252
[TBL] [Abstract][Full Text] [Related]
26. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Dtsch Med Wochenschr; 1987 May; 112(22):873-8. PubMed ID: 3556133
[TBL] [Abstract][Full Text] [Related]
27. [Trental and Cavinton in the treatment of cochleovestibular disorders].
Hahn A; Holcát M
Cesk Otolaryngol; 1984 Jul; 33(4):264-7. PubMed ID: 6333291
[No Abstract] [Full Text] [Related]
28. Pentoxifylline for intermittent claudication.
Med Lett Drugs Ther; 1984 Nov; 26(675):103-4. PubMed ID: 6390108
[No Abstract] [Full Text] [Related]
29. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine).
Kalimo K; Jansen CT
Ann Allergy; 1980 Jan; 44(1):34-7. PubMed ID: 7352689
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and clinical tolerance of parenteral pentoxifylline in the treatment of critical lower limb ischemia. A placebo controlled multicenter study. Norwegian Pentoxifylline Multicenter Trial Group.
Int Angiol; 1996 Mar; 15(1):75-80. PubMed ID: 8739541
[TBL] [Abstract][Full Text] [Related]
31. Intermittent claudication: a controlled study in parallel time of the short-term and long-term effects of cinnarizine.
Barber JH; Reuter CA; Jageneau AH; Loots W
Pharmatherapeutica; 1980; 2(6):401-7. PubMed ID: 7433479
[TBL] [Abstract][Full Text] [Related]
32. Cerebral blood flow in patients with cerebrovascular disorders: study with pentoxifylline.
Hartmann A
Ric Clin Lab; 1981; 11 Suppl 1():243-6. PubMed ID: 7188111
[TBL] [Abstract][Full Text] [Related]
33. Pharmacologic treatment of intermittent claudication.
Porter JM; Bauer GM
Surgery; 1982 Dec; 92(6):966-71. PubMed ID: 7147192
[TBL] [Abstract][Full Text] [Related]
34. [Viscosity of blood and sensorineural hearing loss (author's transl)].
Schulz CE; Richter W; Naujoks J
Laryngol Rhinol Otol (Stuttg); 1977 Apr; 56(4):328-34. PubMed ID: 140979
[TBL] [Abstract][Full Text] [Related]
35. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).
Magnusson M; Höglund P; Johansson K; Jönsson C; Killander F; Malmström P; Weddig A; Kjellén E
Eur J Cancer; 2009 Sep; 45(14):2488-95. PubMed ID: 19540105
[TBL] [Abstract][Full Text] [Related]
36. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
37. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
Herskovits E; Vazquez A; Famulari A; Tamaroff L; Fraiman H; Gonzáles AM; Smud R; Vila J; Matera V
Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
[TBL] [Abstract][Full Text] [Related]
38. [Pentoxifylline medication within the scope of leg-ulcer therapy. Results of a field study using Trental 400].
Pemler K; Penth B; Adams HJ
Fortschr Med; 1979 Jun; 97(21):1019-22. PubMed ID: 437649
[TBL] [Abstract][Full Text] [Related]
39. Cerebral blood flow under hypobaric conditions: effects of pentoxifylline ('Trental' 400).
Koppenhagen K
Pharmatherapeutica; 1984; 4(1):1-5. PubMed ID: 6504944
[TBL] [Abstract][Full Text] [Related]
40. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
